Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

Report of the 113th Annual Meeting of the Association of Physicians of Great Britain and Ireland.

Dominiczak DA, Samani N, Sudlow C, Sansom O, Davies DS.

QJM. 2019 Sep 1;112(9):733-742. doi: 10.1093/qjmed/hcz176. No abstract available.

PMID:
31505684
2.

The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology.

Paasila PJ, Davies DS, Kril JJ, Goldsbury C, Sutherland GT.

Brain Pathol. 2019 Nov;29(6):726-740. doi: 10.1111/bpa.12717. Epub 2019 Mar 22.

PMID:
30803086
3.

Microglia show altered morphology and reduced arborization in human brain during aging and Alzheimer's disease.

Davies DS, Ma J, Jegathees T, Goldsbury C.

Brain Pathol. 2017 Nov;27(6):795-808. doi: 10.1111/bpa.12456. Epub 2016 Dec 12.

PMID:
27862631
4.

STED imaging of tau filaments in Alzheimer's disease cortical grey matter.

Benda A, Aitken H, Davies DS, Whan R, Goldsbury C.

J Struct Biol. 2016 Sep;195(3):345-352. doi: 10.1016/j.jsb.2016.07.003. Epub 2016 Jul 9.

PMID:
27402534
5.

Leadership in Health Systems: A New Agenda for Interactive Leadership.

Chunharas S, Davies DSC.

Health Syst Reform. 2016 Jul 2;2(3):176-178. doi: 10.1080/23288604.2016.1222794. No abstract available.

PMID:
31514590
6.

Dynamic Filament Formation by a Divergent Bacterial Actin-Like ParM Protein.

Brzoska AJ, Jensen SO, Barton DA, Davies DS, Overall RL, Skurray RA, Firth N.

PLoS One. 2016 Jun 16;11(6):e0156944. doi: 10.1371/journal.pone.0156944. eCollection 2016.

7.

Morbidity matters: challenges for research.

Hobbs FD, Baker M, Davies DS.

Br J Gen Pract. 2015 Apr;65(633):e215-6. doi: 10.3399/bjgp15X684301. No abstract available.

8.

GP antibiotic overuse and microbial resistance.

Shallcross LJ, Davies DS.

Br J Gen Pract. 2015 Feb;65(631):61-2. doi: 10.3399/bjgp15X683413. No abstract available.

9.

Antibiotic overuse: a key driver of antimicrobial resistance.

Shallcross LJ, Davies DS.

Br J Gen Pract. 2014 Dec;64(629):604-5. doi: 10.3399/bjgp14X682561. No abstract available.

10.

Cofilin rods and aggregates concur with tau pathology and the development of Alzheimer's disease.

Rahman T, Davies DS, Tannenberg RK, Fok S, Shepherd C, Dodd PR, Cullen KM, Goldsbury C.

J Alzheimers Dis. 2014;42(4):1443-60. doi: 10.3233/JAD-140393.

PMID:
25024349
11.

Clinical research and healthcare outcomes.

Davies DS.

Ann Oncol. 2011 Nov;22 Suppl 7:vii1. doi: 10.1093/annonc/mdr417. No abstract available.

PMID:
22039137
12.

Spitzenkörper, vacuoles, ring-like structures, and mitochondria of Phanerochaete velutina hyphal tips visualized with carboxy-DFFDA, CMAC and DiOC6(3).

Zhuang X, Tlalka M, Davies DS, Allaway WG, Watkinson SC, Ashford AE.

Mycol Res. 2009 Apr;113(Pt 4):417-31. doi: 10.1016/j.mycres.2008.11.014. Epub 2008 Dec 7.

PMID:
19114102
13.

Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues.

Key J, Hodgson S, Omar RZ, Jensen TK, Thompson SG, Boobis AR, Davies DS, Elliott P.

Cancer Causes Control. 2006 Aug;17(6):759-70.

14.

A strategy for investigating the CYP superfamily using targeted antibodies is a paradigm for functional genomic studies.

Edwards RJ, Boobis AR, Davies DS.

Drug Metab Dispos. 2003 Dec;31(12):1476-80. Review.

PMID:
14625344
15.

Retention of fluorescent probes during aldehyde-free anhydrous freeze-substitution.

Hyde GJ, Davies DS, Cole L, Ashford AE.

J Microsc. 2003 May;210(Pt 2):125-30.

16.

The mutational signature of alpha-hydroxytamoxifen at Hprt locus in Chinese hamster cells.

Yadollahi-Farsani M, Davies DS, Boobis AR.

Carcinogenesis. 2002 Nov;23(11):1947-52.

PMID:
12419845
17.

Surrogacy in antiviral drug development.

Shaunak S, Davies DS.

Br J Clin Pharmacol. 2002 Jul;54(1):75-80. Review.

18.

Lifestyle risks for three disease outcomes in spinal cord injury.

Davies DS, McColl MA.

Clin Rehabil. 2002 Feb;16(1):96-108.

PMID:
11837530
19.

Food-derived heterocyclic amine mutagens: variable metabolism and significance to humans.

Gooderham NJ, Murray S, Lynch AM, Yadollahi-Farsani M, Zhao K, Boobis AR, Davies DS.

Drug Metab Dispos. 2001 Apr;29(4 Pt 2):529-34.

PMID:
11259345
20.

Identification of theta-class glutathione S-transferase in liver cytosol of the marmoset monkey.

Schulz TG, Wiebel FA, Thier R, Neubert D, Davies DS, Edwards RJ.

Arch Toxicol. 2000 May;74(3):133-8.

PMID:
10876998
21.

The potential of acetaminophen as a prodrug in gene-directed enzyme prodrug therapy.

Thatcher NJ, Edwards RJ, Lemoine NR, Doehmer J, Davies DS.

Cancer Gene Ther. 2000 Apr;7(4):521-5.

22.

Nucleosomes bind to cell surface proteoglycans.

Watson K, Gooderham NJ, Davies DS, Edwards RJ.

J Biol Chem. 1999 Jul 30;274(31):21707-13.

23.

Interaction of the transactivating protein HIV-1 tat with sulphated polysaccharides.

Watson K, Gooderham NJ, Davies DS, Edwards RJ.

Biochem Pharmacol. 1999 Apr 1;57(7):775-83.

PMID:
10075083
24.

Genetic analysis of PHIP intestinal mutations in MutaMouse.

Lynch AM, Gooderham NJ, Davies DS, Boobis AR.

Mutagenesis. 1998 Nov;13(6):601-5.

PMID:
9862191
25.

Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P450 in humans.

Edwards RJ, Adams DA, Watts PS, Davies DS, Boobis AR.

Biochem Pharmacol. 1998 Aug 1;56(3):377-87.

PMID:
9744576
26.

Reduced hepatic expression of CYP7A1 and CYP2C13 in rats with spontaneous hyperlipidaemia.

Brassil PJ, Debri K, Nakura H, Kobayashi S, Davies DS, Edwards RJ.

Biochem Pharmacol. 1998 Jul 15;56(2):253-7.

PMID:
9698080
27.

Identification of CYP2E1 in marmoset monkey.

Schulz TG, Thiel R, Davies DS, Edwards RJ.

Biochim Biophys Acta. 1998 Feb 17;1382(2):287-94.

PMID:
9540800
28.

Reduction of the viral load of HIV-1 after the intraperitoneal administration of dextrin 2-sulphate in patients with AIDS.

Shaunak S, Thornton M, John S, Teo I, Peers E, Mason P, Krausz T, Davies DS.

AIDS. 1998 Mar 5;12(4):399-409.

PMID:
9520170
29.

Specific inhibition of human CYP1A2 using a targeted antibody.

Adams DA, Edwards RJ, Davies DS, Boobis AR.

Biochem Pharmacol. 1997 Jul 1;54(1):189-97.

PMID:
9296366
30.

Anti-HIV type 1 activity of sulfated derivatives of dextrin against primary viral isolates of HIV type 1 in lymphocytes and monocyte-derived macrophages.

Javan CM, Gooderham NJ, Edwards RJ, Davies DS, Shaunak S.

AIDS Res Hum Retroviruses. 1997 Jul 1;13(10):875-80.

PMID:
9197381
31.

Analysis of terfenadine in human plasma using microbore high-performace liquid chromatography-electrospray ionisation mass spectrometry.

Adams DA, Murray S, Clifford CP, Rendell NB, Davies DS, Taylor GW.

J Chromatogr B Biomed Sci Appl. 1997 Jun 6;693(2):345-51.

PMID:
9210438
32.

Assessing human risk to heterocyclic amines.

Gooderham NJ, Murray S, Lynch AM, Yadollahi-Farsani M, Zhao K, Rich K, Boobis AR, Davies DS.

Mutat Res. 1997 May 12;376(1-2):53-60.

PMID:
9202738
33.

Relationship between aerobic fitness and metabolic recovery from intermittent exercise in endurance athletes .

Bell GJ, Snydmiller GD, Davies DS, Quinney HA.

Can J Appl Physiol. 1997 Feb;22(1):78-85.

PMID:
9018410
34.

The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice.

Clifford CP, Adams DA, Murray S, Taylor GW, Wilkins MR, Boobis AR, Davies DS.

Eur J Clin Pharmacol. 1997;52(4):311-5.

PMID:
9248771
35.

Inducibility of cytochromes P-450 by dioxin in liver and extrahepatic tissues of the marmoset monkey (Callithrix jacchus).

Schulz TG, Neubert D, Davies DS, Edwards RJ.

Biochim Biophys Acta. 1996 Nov 14;1298(1):131-40.

PMID:
8948497
36.

Heterocyclic amines: evaluation of their role in diet associated human cancer.

Gooderham NJ, Murray S, Lynch AM, Edwards RJ, Yadollahi-Farsani M, Bratt C, Rich KJ, Zhao K, Murray BP, Bhadresa S, Crosbie SJ, Boobis AR, Davies DS.

Br J Clin Pharmacol. 1996 Jul;42(1):91-8. Review.

37.

Dissecting the function of cytochrome P450.

Boobis AR, Edwards RJ, Adams DA, Davies DS.

Br J Clin Pharmacol. 1996 Jul;42(1):81-9. Review.

38.

Mutational spectra of the dietary carcinogen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine(PhIP) at the Chinese hamsters hprt locus.

Yadollahi-Farsani M, Gooderham NJ, Davies DS, Boobis AR.

Carcinogenesis. 1996 Apr;17(4):617-24.

PMID:
8625468
39.

Developmental changes in hepatic activation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rabbit.

Rich KJ, Zhao K, Davies DS, Boobis AR, Gooderham NJ.

Carcinogenesis. 1996 Mar;17(3):555-8.

PMID:
8631144
40.

Induction of cytochromes P450 by dioxins in liver and lung of marmoset monkeys (Callithrix jacchus).

Schulz TG, Neubert D, Davies DS, Edwards RJ.

Adv Exp Med Biol. 1996;387:443-6. No abstract available.

PMID:
8794239
41.

Enzymic and interindividual differences in the human metabolism of heterocyclic amines.

Boobis AR, Gooderham NJ, Edwards RJ, Murray S, Lynch AM, Yadollahi-Farsani M, Davies DS.

Arch Toxicol Suppl. 1996;18:286-302. Review.

PMID:
8678804
42.

Chemical methods for assessing systemic exposure to dietary heterocyclic amines in man.

Davies DS, Gooderham NJ, Murray S, Lynch A, de la Torre R, Segura J, Boobis AR.

Arch Toxicol Suppl. 1996;18:251-8. Review.

PMID:
8678801
43.

Distribution and induction of CYP3A1 and CYP3A2 in rat liver and extrahepatic tissues.

Debri K, Boobis AR, Davies DS, Edwards RJ.

Biochem Pharmacol. 1995 Dec 22;50(12):2047-56.

PMID:
8849332
44.

Lower levels of urinary 2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx) in humans with higher CYP1A2 activity.

Sinha R, Rothman N, Mark SD, Murray S, Brown ED, Levander OA, Davies DS, Lang NP, Kadlubar FF, Hoover RN.

Carcinogenesis. 1995 Nov;16(11):2859-61.

PMID:
7586210
45.

Enoxacin is an inducer of CYP1A2 in rat liver.

Schulz TG, Stahlmann R, Edwards RJ, Debri K, Davies DS, Neubert D.

Biochem Pharmacol. 1995 Oct 26;50(9):1517-20.

PMID:
7503804
46.

Determination of human hepatic cytochrome P4501A2 activity in vitro use of tacrine as an isoenzyme-specific probe.

Spaldin V, Madden S, Adams DA, Edwards RJ, Davies DS, Park BK.

Drug Metab Dispos. 1995 Sep;23(9):929-34.

PMID:
8565783
47.

Extra-nuclear location of histones in activated human peripheral blood lymphocytes and cultured T-cells.

Watson K, Edwards RJ, Shaunak S, Parmelee DC, Sarraf C, Gooderham NJ, Davies DS.

Biochem Pharmacol. 1995 Jul 31;50(3):299-309.

PMID:
7646532
48.

Expression and distribution of cholesterol 7 alpha-hydroxylase in rat liver.

Brassil PJ, Edwards RJ, Davies DS.

Biochem Pharmacol. 1995 Jul 31;50(3):311-6.

PMID:
7544128
49.

Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes.

Edwards RJ, Singleton AM, Murray BP, Davies DS, Boobis AR.

Biochem Pharmacol. 1995 Jan 6;49(1):39-47.

PMID:
7840781
50.

Systemic exposure to dietary heterocyclic amines in man.

Davies DS, Gooderham NJ, Murray S, Lynch A, de la Torre R, Segura J, Boobis AR.

Princess Takamatsu Symp. 1995;23:190-6. Review.

PMID:
8844810

Supplemental Content

Loading ...
Support Center